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ABSTRACT
In the early 1950’s, ‘host-controlled variation in
bacterial viruses’ was reported as a non-hereditary
phenomenon: one cycle of viral growth on certain
bacterial hosts affected the ability of progeny virus
to grow on other hosts by either restricting or
enlarging their host range. Unlike mutation, this
change was reversible, and one cycle of growth in
the previous host returned the virus to its original
form. These simple observations heralded the dis-
covery of the endonuclease and methyltransferase
activities of what are now termed Type I, II, III and
IV DNA restriction-modification systems. The Type II
restriction enzymes (e.g. EcoRI) gave rise to recom-
binant DNA technology that has transformed mo-
lecular biology and medicine. This review traces the
discovery of restriction enzymes and their continuing
impact on molecular biology and medicine.
INTRODUCTION
Restriction endonucleases (REases) such as EcoRI are
familiar to virtually everyone who has worked with
DNA. Currently, >19000 putative REases are listed on
REBASE (http://rebase.neb.com) (1). REases are classiﬁed
into four main types, Type I, II, III and IV, with subdiv-
isions for convenience; almost all require a divalent metal
cofactor such as Mg2+ for activity (Table 1 and Figure 1).
Type II REases represent the largest group of characterized
enzymes owing to their usefulness as tools for recombinant
DNA technology, and they have been studied extensively.
Over 300 Type II REases, with >200 different sequence-
speciﬁcities, are commercially available. Far fewer Type I,
III and IV enzymes have been characterized, but putative
examples are being identiﬁed daily through bioinformatic
analysis of sequenced genomes (Table 1).
Here we present a non-specialists perspective on import-
ant events in the discovery and understanding of REases.
Studies of these enzymes have generated a wealth of
information regarding DNA–protein interactions and
catalysis, protein family relationships, control of restric-
tion activity and plasticity of protein domains, as well
as providing essential tools for molecular biology
research. Discussion of the equally fascinating DNA-
methyltransferase (MTase) enzymes that almost always
accompany REases in vivo is beyond the scope of this
review, but we note that base ﬂipping, ﬁrst discovered in
the HhaI MTase (2), is not conﬁned to these enzymes
alone, but appears to be a common phenomenon that is
also used by certain REases (3) and in other nucleic acid-
binding enzymes (4–7).
Most research interest has focused on Type I and II
enzymes for historical and practical reasons, so this
history is weighted to their treatment. The molecular,
genetic and enzymological properties of these have been
extensively reviewed [see e.g. (8–12)], and separate reviews
of the Type I, III and IV systems appear elsewhere in this
journal.
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THE FIRST HIGHLIGHTS
Discovery of ‘host-controlled variation’
Many important scientiﬁc developments in the ﬁrst half of
the 20th century laid the groundwork for to the discovery
of restriction and modiﬁcation (R-M). These included the
discoveries of radiation and to the ability to incorporate
isotopes in living cells; the molecular building blocks of
DNA, RNA and protein; ‘ﬁlterable agents’ (viruses); the
isolation of Escherichia coli and other bacteria, and of
their viruses [called (bacterio)phage] and plasmids.
Enabling technical advances included development of
electron microscopy, ultracentrifugation, chromatog-
raphy, electrophoresis and radiographic crystallography.
Key was the emerging ﬁeld of microbial genetics, which
ﬂourished owing to the discovery of lysogeny, conjuga-
tion, transduction, recombination and mutation.
Preliminary descriptions of the phenomenon of R-M
were published by Luria and Human (1952) (13),
Anderson and Felix (1952) (14) and Bertani and Weigle
(1953) (15). These reports of ‘host-controlled variation in
bacterial viruses’ were reviewed by Luria (1953) (16).
Host-controlled variation referred to the observation
that the efﬁciency with which phage infected new bacterial
hosts depended on the host on which they previously
grew. Phage that propagated efﬁciently on one bacterial
strain could lose that ability if grown for even a single
cycle on a different strain. The loss was not due to
mutation, and one cycle of growth on the previous
Table 1. Characterization and organization of the genes and subunits of the four Types of restriction enzymes
Type Type I Type II Type III Type IV
Features Oligomeric REase and MTase
complex
Require ATP hydrolysis for
restriction
Cleave variably, often far
from recognition site
‘DEAD-box’ translocating
REase
bipartite DNA recognition
domain
Separate REase and MTase
or combined
REaseMTase fusion
Cleave within or at ﬁxed
positions close to
recognition site
Many different subtypes
Combined REase+MTase
complex
ATP required for restriction
Cleave at ﬁxed position
outside recognition site
‘DEAD-box’ REase
Methylation-dependent REase
Cleave at variable distance
from recognition site
Cleave m6A, m5C, hm5C
and/or other modiﬁed
DNA
Many different types
Example e.g. EcoKI e.g. EcoRI e.g. EcoP1I No ‘typical’ example
Genes hsdR, hsdM, hsdS e.g. ecorIR, ecorIM e.g. ecoP1IM, ecoP1IR e.g. mcrA, mcrBC, mrr
Subunits 135, 62 and 52 kDa 31 and 38 kDa for EcoRI 106 and 75 kDa for
EcoP1I
Unrelated proteins
Proteins REase: 2R+ 2M+ S Orthodox REase: 2R REase: 1 or 2 R+2M Varies
MTase: 2M+S (±2R) Orthodox MTase: M MTase: 2M (±2R)
REBASE 104 enzymes, 47 genes cloned,
34 genes sequenced,
5140 putatives
3938 enzymes, 633 genes
cloned, 597 sequenced,
9632 putatives
21 enzymes, 19 genes cloned
& sequenced, 1889
putatives
18 enzymes & genes cloned,
15 sequenced, 4822
putatives
Type I and II are currently divided in 5 and 11 different subclasses, respectively. Few enzymes have been well-characterized, but based on the current
avalanche of sequence information many putative genes belonging to all Types and subtypes are being identiﬁed and listed on the restriction enzyme
website (http://rebase.neb.com). The modiﬁcation-dependent Type IV enzymes are highly diverse and only a few have been characterized in any
detail. In each case, an example is given of one of the best-characterized enzymes within the different Types I, II and III. Note that Type II enzymes
range from simple (shown here for EcoRI) to more complex systems (see Table 2 for the diversity of Type II subtypes).
REBASE count is as of 16 September 2013 (http://rebase.neb.com/cgi-bin/statlist).
Figure 1. Schematic representation of the functional roles ﬁlled in dif-
ferent ways in R-M systems. The functions served include the follow-
ing: S, DNA sequence speciﬁcity; MT, methyltransferase catalytic
activity; M, SAM binding; E, endonuclease; T, translocation. Boxes
outline functions that are ﬁlled by distinct protein domains. Different
colours indicate different functions, while different boxes represent
distinct domains. Domains in a single polypeptide are abutted, and
those in separate polypeptides spaced apart. The order of domains in
a polypeptide may vary—e.g. not all Type IIS enzymes have the
cleavage domain at the C-terminus. In some cases, functions are
integrated with each other, e.g. S and E functions of Type IIP
(striped box); in other cases, separate domains carry them out, e.g.
Type IIS. See Table 2 for the complexity and diversity of Type II
subtypes. The large families of Type I and Type II systems are currently
subdivided in 5 and 11 different groups, respectively. The Type I
families are distinguished by homology; the Type II groups are distin-
guished by catalytic properties rather than sequence homology. Type
IV enzymes were initially identiﬁed as hydroxymethylation-dependent
restriction enzymes and currently comprise a highly diverse family. Two
examples are shown with and without a translocation domain.
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strain returned the virus to its original state once more.
R-M systems of all types initially were investigated in
this same way, by comparing the ‘efﬁciency of plating’
(eop; number of plaques on the test host divided by the
number of plaques on a permissive host) on alternate
bacterial hosts (17–21). Eop values would range from
101 to 105, thus indicating that R-M systems were
effective barriers to the uptake of DNA; see (16,22–26)
for early reviews.
DNA modiﬁcation
A decade after these initial reports, Werner Arber and
Daisy Dussoix, using phage lambda as experimental
system, showed that it was the phage DNA that carried
the host-range imprint (17). Different speciﬁcities could be
imprinted concomitantly both by the bacterium itself (by
what were later recognized to be the Type I EcoKI and
EcoBI systems) and by phage P1 in its latent prophage
state (the Type III EcoP1I system). Gunther Stent sug-
gested that DNA methylation might be the basis for the
modiﬁcation imprint, thus prompting Arber to show that
methionine was required in the growth medium to
produce the imprint on the DNA (27). This important
ﬁnding coincided with the discovery of RNA-
methyltransferase and MTase activities in bacteria that
catalysed the formation of m5C and m6A (28). Arber’s
interest in the biochemical mechanisms of R-M was
driven in part by insight that R-M enzymes would prove
useful for analysing DNA molecules and DNA–protein
interactions. He concluded a landmark 1965 review of
host-controlled modiﬁcation with the following words:
‘Looking toward future developments . . . it is to be
hoped that the enzymes involved in production and
control of host speciﬁcity will be isolated and
characterized. Such studies, paralleled with investigations
of the genes controlling R-M and of their expression,
should eventually permit an explanation of the high
degree of strain speciﬁcity, for example ‘‘by a mechanism
of recognition of certain base sequences’’. If this last idea
should be correct one may further speculate that a restric-
tion enzyme might ‘‘provide a tool for the sequence-
speciﬁc cleavage of DNA’’ ’ (22) (our double quotes).
Sequence-speciﬁc DNA-cleavage
As chance would have it, the R-M systems studied by
Arber, Type I and Type III (25), do not provide simple
enzymes for the sequence-speciﬁc cleavage of DNA (see
further below). However, REases with the desired
sequence-speciﬁc cleavage were soon isolated, and these
set the stage for the advances in gene analysis and ma-
nipulation, collectively called ‘recombinant DNA technol-
ogy’, that quickly followed. The ﬁrst of these new
enzymes, HindII, was discovered in Hamilton (‘Ham’)
Smith’s laboratory at Johns Hopkins Medical School in
1970 (29). This was subsequently termed a Type II REase
as its properties were distinct from the Type I REases (25).
Puriﬁed from Haemophilus inﬂuenzae serotype d, HindII
(originally called endonuclease R) was found to act as a
homodimer and to cleave DNA at the symmetric (though
degenerate) sequence GTY’RAC (Y=C or T; R=A or
G;’ indicates the cut site) (29,30). Subsequently, what was
thought to be pure HindII was found to be a mixture of
HindII and a second REase made by the same bacterium,
HindIII. HindIII cleaved DNA at a different symmetric
sequence, A’AGCTT (31,32); [see (33) for a thought-
provoking discussion]. The existence of HindIII came to
light during experiments to characterize the MTase
activities of H. inﬂuenzae. These experiments showed
that the HindII and HindIII MTases acted at the same
DNA sequences as those cleaved by the REases. They
modiﬁed these sequences rather than cleaving them,
producing GTYRm6AC and m6AAGCTT, respectively
(34–36).
The universe of enzymes in this Type II category
expanded rapidly. As Smith’s work proceeded on the
east coast of the USA, REases with similar behaviour
but different speciﬁcity were discovered in the laboratory
of Herb Boyer at the University of California, San
Francisco, on the west coast. Here, PhD student Robert
Yoshimori (37) beneﬁted from the experience of Daisy
Dussoix, who had moved from Werner Arber’s lab to
UCSF. Yoshimori investigated restriction systems
present on plasmids in clinical E. coli isolates, and
puriﬁed what became known as EcoRI and EcoRII
(37,38). The EcoRI REase was found to cleave G’AATT
C (39,40) and the corresponding M.EcoRI MTase to
modify the inner adenines in this sequence, producing
GAm6ATTC (41). The EcoRII REase was found to
cleave ‘CCWGG (W=A or T), and the M.EcoRII
MTase to modify the inner cytosines, producing
Cm5CWGG (42,43).
Staggered cuts and the advent of genetic engineering
In contrast to the Type I and Type III enzymes studied in
the 1960’s, EcoRI and HindIII cleave DNA within their
recognition sites and, most importantly, produce stag-
gered cuts. Since the recognition sites are symmetric, this
means that every fragment is ﬂanked by the same single-
stranded extension, allowing any fragment to anneal (via
the extensions) to any other fragment, thus setting the
stage for recombining DNA fragments and ‘cloning’.
These ﬁndings were presented at the 1972 EMBO
Workshop on Restriction, organized by Werner Arber
(see Supplement S1 for details of the program and at-
tendees). Figure 2 shows a photograph of participants at
this Workshop, recalled by Noreen Murray as the most
exciting meeting in the history of the REases, with discus-
sions on the impact of this vital new information on
‘sticky ends’ and the implications for novel DNA manipu-
lation. The recently described DNA ligase (44) would
allow the joining of DNA fragments with the same
sticky ends. EcoRI and HindIII spurred the development
of recombinant DNA work through the availability of
both puriﬁed enzymes and of replicatable carriers known
as vectors. Both phage lambda (45) and various plasmids
(46,47) were developed into vectors into which DNA frag-
ments generated by EcoRI and HindIII could be ligated.
Fittingly, in 1978, Werner Arber was awarded the
Nobel Prize together with Dan Nathans and Ham Smith
Nucleic Acids Research, 2013 3
in recognition for their pioneering work on R-M (www.
nobelprize.org).
Emerging genetic and enzymatic complexity
While the 1972 review by Matt Meselson et al. (26)
mentions only the recognition sequence of HindII, the
pace soon quickened. The discovery of new restriction
enzymes skyrocketed, as laborious in vivo phage-plating
assays were replaced by rapid in vitro DNA-cleavage
assays of cell extracts. Elucidation of differences in recog-
nition and cutting led to the classiﬁcation of additional
distinct classes, or types, of restriction enzymes (25,48),
which with extensions and subdivisions has stood the
test of time: Type I (exempliﬁed by EcoKI, EcoBI,
EcoR124, the ‘classical’ enzymes); Type II (EcoRI,
HindIII, EcoRV, the ‘orthodox’ enzymes); and Type III
(EcoP1I and EcoP15I), Table 1 and Figure 1. Type IV
(modiﬁcation-dependent REases Mcr and Mrr) was
added later (49). Sequencing and biochemistry have
since led to subdivisions within the Type I (see below)
and Type II systems (Table 2) [see (49,50) and http://
rebase.neb.com for nomenclature and details].
The recombinant DNA scare
In their 1975 review (51), Nathans and Smith discuss
methods for DNA cleavage and separation of the resulting
fragments on gels, as well as the use of REases in
other applications, e.g. the physical mapping of chromo-
somes, taking Simian Virus SV40 (SV40) as an example.
The debate on the safety of recombinant DNA technology
started soon after the 1972 EMBO Workshop and reports
on the transfer of eukaryotic DNA into E. coli [docu-
mented by (52)]. The debate was extremely heated, but
by 1990 many of the fears had abated as the anticipated
dangers did not materialize and the advantages of DNA
cloning, and the ability to produce large quantities of
pharmaceutically important proteins such as insulin,
hormones and vaccines became clear.
FURTHER HIGHLIGHTS IN THE STUDY OF TYPE I
R-M SYSTEMS
Type I families are deﬁned by complementation and
display sequence conservation
Type I REases were originally identiﬁed in E. coli and
other enteric organisms as barriers to DNA entry. They
turned out to be oligomeric proteins encoded by the three
host speciﬁcity determinant (hsd) genes: a restriction (R),
modiﬁcation (M) and recognition (S for speciﬁcity) gene,
respectively (Table 1 and Figure 1). Before the develop-
ment of DNA sequencing, genetic complementation tests
deﬁned the hsdR, hsdM and hsdS genes (53,54). DNA hy-
bridization studies, and probing with antibodies directed
at EcoKI, established that EcoKI and EcoBI were more
closely related to each other than to EcoAI, the Type I
system in E. coli 15T [reviewed in (8)]. This approach
based on biological interaction led to the division of
these systems into families: the Type IA (EcoKI, EcoBI,
Figure 2. Photograph of the participants at the EMBO Workshop on restriction in Leuenberg (Basel), Switzerland, 26–30 September 1972, organized
by Werner Arber, who took the picture (Archive Noreen Murray). Supplement S1 contains a list with names of the attendees and the program of this
meeting, and puts names to faces as far as the attendees could be identiﬁed (from the archives of Noreen Murray and Werner Arber).
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EcoDI and Salmonella typhimurium StySPI); Type IB
(EcoAI, EcoEI and Citrobacter freundii CfrAI); Type IC
(EcoR124, EcoDXXI, EcoprrI) (8); and later, Type ID
(StyBLI and Klebsiella pneumoniae KpnAI) (9,55,56) and
Type IE (KpnBI) (57); see reviews for further details (8–
10,58,59). Other organisms will have their own families,
for example, Staphylococcus aureus has at least two
families [(60) and unpublished DTFD results].
Preparation, cofactor requirements and structures
Landmark studies on puriﬁed enzymes in the wake of the
1962 Arber and Dussoix articles (17,61) date to 1968. Stu
Linn and Werner Arber in Switzerland and Matt
Meselson and Bob Yuan in the USA, respectively,
puriﬁed EcoBI and EcoKI. They used restriction of
phages fd and lambda as their assay for detecting the
enzymes during puriﬁcation, a laborious process (62,63).
This was no simple matter; Bob Yuan recalls that ‘the fall
ﬂew by in deep frustration’ until he and Matt discovered
that the enzyme needed S-adenosylmethionine (SAM) for
activity in addition to Mg2+and ATP (See Supplement S2
for his personal story). The same cofactor requirement
was also found for EcoBI (62,64), reviewed in (25,26).
Twenty-ﬁve years later, we have come to appreciate that
SAM, like ATP, is a widely used cofactor in many meta-
bolic reactions (65,66).
A long-awaited breakthrough did not happen until
much later: The structures of the subunits and assembled
Type I R-M enzymes. Two structures of S subunits
appeared in 2005 and culminated in 2012 with the struc-
ture of two complete R-M enzymes containing two R
subunits, two M subunits and one S subunit (67–69).
Type I enzymes cut away from the target site
In 1972, Horiuchi and Zinder showed that the DNA
recognition site of EcoBI is not the cleavage site (70).
They cut 3H-labelled double-strand RF DNA of phage
f1 (a relative of phage M13) with EcoBI, denatured and
renatured the DNA and then treated with EcoBI a second
time. This resulted in a heterogeneous distribution of
small DNA fragments on alkaline sucrose gradients
leading to the conclusion that EcoBI cuts at a variable
distance from its target site. This feature is now known
to be common to all Type I restriction enzymes. It was
later shown by Studier that EcoKI would preferentially
cleave DNA approximately half-way between consecutive
target sites (71). This feature is also common to all Type I
restriction enzymes although the distribution of cleavage
locations can be broad.
DNA translocation to reach the cutting sites uses
molecular motors
Translocation was ﬁrst observed in electron microscope
(EM) studies that showed DNA looping by EcoBI and
EcoKI. These were interpreted as reaction intermediates,
formed by the enzymes translocating along the DNA
while remaining attached to their recognition sites
(72,73). In the case of EcoKI, studies with full-length
phage lambda DNA and relaxed or supercoiled circular
DNA showed that EcoKI translocates the DNA past
itself, concomitant with a large conformational change
of the enzyme, creating large bidirectional loops clearly
visible in the EM. Recent studies conﬁrm that on DNA
binding, the enzyme strongly contracts from an open to a
compact form (58,69,74). In contrast, EcoBI appeared to
form loops in only one direction. Later studies with EcoBI
did show supercoiled structures like EcoKI; however,
translocation was still unidirectional, and without any
apparent strand selectivity in the cleavage reaction
(75,76). The translocation process would explain the
cleavage observed half-way between consecutive target
sites on a DNA molecule as two translocating enzyme
Table 2. Nomenclature of Type II restriction enzymes
Subtype Features of restriction enzymesa Examples
Type IIP Palindromic recognition sequence; recognized by both homodimeric and monomeric
enzymes; cleavage occurs symmetrically, usually within the recognition sequence
Prototypes EcoRI & EcoRV
Type IIA Asymmetric recognition sequence FokI
Type IIB Cleavage on both sides of the recognition sequence BcgI
Type IIC Single, combination R-M polypeptide HaeIV
Type IIE Two sequences required for cleavage, one serving as allosteric effector EcoRII, Sau3AI
Type IIF Two sequences required for cleavage, concerted reaction by homotetramer SﬁI
Type IIG Requires AdoMet cofactor for both R-M Eco57I
Type IIH Separate M and S subunits; MTase organization similar to Type I systems BcgI
Type IIM Require methylated recognition sequence; Type IIP or Type IIA DpnI
Type IIS Asymmetric recognition sequence; cleavage at ﬁxed positions usually outside recogni-
tion sequence
FokI
Type IIT Heterodimeric restriction enzyme. Bpu10I, BslI
Putatives All subtypes
Control Control proteins of Type II restriction enzymes C.BamHI, C.PvuII
The characteristics of the orthodox Type IIP enzymes originally distinguished this group of enzymes from the Type I and III R-M systems. Type IIP
is the largest group, owing to its valuable role in molecular science and its commercial value, but the current classiﬁcation and growing number of
R-M systems (putatively) identiﬁed, makes it clear that Type II enzymes are highly diverse and the boundaries with the other types are beginning to
blur; see also Figure 3 and text for details.
aThese classiﬁcations reﬂect enzyme properties and activities, and not their evolutionary relationships. The classiﬁcations are not exclusive, and one
enzyme can often belong several classes. Thus BcgI, for example, is Type IIA, B, C, G and H (see text for details).
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molecules would collide roughly half-way between target
sites.
The R-subunit of Type I enzymes belongs to the SNF2
helicase/translocase superfamily of proteins. These appear
to be the result of an ancient fusion between nuclease and
ATP-dependent RecA-like (AAA+or ‘motor’) domains, a
linkage found in many enzymes involved in DNA repair,
replication, recombination and chromosome remodelling
(77–88). As such, Type I enzymes could prove useful for
understanding the action of SNF2 enzymes in higher
organisms, including the coordinated steps of DNA
scanning, recognition, binding and alteration of the
helical structure, that allow other domains or subunits
to move and touch the DNA. All of these steps are
required to prevent indiscriminate nuclease activity (69).
The key to the functionality of the Type I REase and
other SNF2 proteins is their enormous ﬂexibility, allowing
large conformational changes. First noticed for EcoKI by
Yuan et al (73), and more recently for RecB and EcoR124
(69,89), large protein motions may be a general feature of
SNF2 proteins. In line with such large-scale domain
movement, mutational analysis of EcoR124 showed
long-range effects, e.g. nuclease mutants affect the
distant helicase domain leading to a reduced translocation
and ATP usage rate, a decrease in the off rate, slower
restart and turnover. In other words, the nuclease and
motor domain together are ‘more than the sum of their
parts’ (89,90).
Plasticity of type I DNA sequence recognition: hybrid
speciﬁcities and phase variation
Type I enzymes recognize bipartite DNA sequences [e.g.
AAC(N6)GTGC for EcoKI]. The S subunit has a
duplicated organization: two 150 aa variable regions
alternate with smaller conserved regions, which are
highly similar within each of the ﬁve families. Each
variable region recognizes one part of the bipartite
target sequence.
A key event in understanding the signiﬁcance and mech-
anism of variation of sequence speciﬁcity was the discov-
ery of a brand-new speciﬁcity resulting from a genetic
cross (91,92). As a result of crossing-over in the conserved
central region between the two variable regions, hybrid
speciﬁcities were found. This change in speciﬁcity was
found to occur in vivo and in vitro and was ﬁrst noted
for Salmonella species (91–94). An extensive treatment of
this topic is found in the accompanying Type I review.
A variety of genetic processes promote variation in S
subunits proteins of Type I and Type III enzymes. In
Lactococcus lactis, entering plasmids may bring hsdS
genes with them (95). The segmented organization
of hsdS, with two DNA recognition domains, lends
itself to variation by DNA rearrangement. Site-speciﬁc
recombination leads to expression of S proteins with
alternative recognition domains in Mycoplasma
pulmonis, thus generating combinatorial variations of rec-
ognition sequence (96). Such plasticity of restriction spe-
ciﬁcity is also inferred in Bacteroides fragilis (97) and other
species.
FURTHER HIGHLIGHTS IN THE STUDY OF TYPE II
R-M SYSTEMS
Subdivisions of type II enzymes
Type II REases are deﬁned rather broadly as enzymes
that cleave DNA at a ﬁxed position with respect to their
recognition sequence, and produce distinct DNA-
fragment banding patterns during gel electrophoresis.
These REases are extremely varied and occur in many
structural forms. The Type II classiﬁcation was used ori-
ginally to deﬁne the simplest kind of REases, exempliﬁed
by HindII and EcoRI, that recognize symmetric DNA
sequences and require Mg2+ ions for cleavage activity
(25). Enzymes of this sort generally act as homodimers
and cleave DNA within their recognition sequences.
In vivo, they function in conjunction with a separate
modiﬁcation MTase that acts independently as a
monomer (Table 1). The ﬁrst distinction made among
Type II enzymes concerned REases such as HphI and
FokI that recognize asymmetric sequences and cleave a
short distance away, to one side. These were designated
Type IIS (98).
As the number of REases producing distinct frag-
ments grew, it became clear that many unrelated
proteins were included in the category (99). Rather than
dividing these into further Types based on their
phylogenies, it was agreed that ‘Type II’ should become
a utilitarian classiﬁcation that reﬂected enzymatic
behaviour rather than evolutionary relatedness, and for
convenience, a number of Type II groups, corresponding
to particular enzymatic behaviours, were deﬁned (49)
(Table 2). Each of these groups, A, B, C, E, F, G, H,
M, P, S and T, should be thought of, not as an exclusive
subdivision, but rather as an icon that signiﬁes some
speciﬁc property. Enzymes may exhibit more than one
salient property and thus belong to more than one
group. HindIII and EcoRI remain simple; they are
members of just the one, Type IIP, group (‘P’ for
Palindromic). BcgI, in contrast, is complicated since it
recognizes an asymmetric DNA sequence (= Type IIA);
cleaves on both sides of that sequence (= Type IIB); and
comprises a fused endonuclease-methyltransferase subunit
(= Type IIC) plus a Type I-like DNA-speciﬁcity subunit
(= Type IIH). BcgI, thus, is a member of multiple groups
(100–102). DpnI (Gm6A’TC) is a Type IIM REase, which
cleaves its recognition sequence only when the sequence is
methylated (103). DpnI is also a member of the Type IIP
group since its recognition sequence is palindromic
sequence and cleavage is internal and symmetric
(Figure 3 and http://rebase.neb.com).
Type IIP (‘orthodox’) REases such as EcoRI and
HindIII were crucial to the development of recombinant
DNA technology. Certain ‘unorthodox’ enzymes have
also been widely used. Sau3AI (’GATC) is a monomeric
Type IIE REase that dimerizes on the DNA, inducing
DNA loops. Two recognition sites must be bound for
activity; one is cleaved while the other acts as allosteric
effector (104). EcoRII is somewhat similar, and many
REases are now known to cleave only as dimers of
dimers bound to two separate sites.
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Predicting enzyme families: sequences, structures and
bioinformatics
Early amino acid sequences of Type II enzymes (e.g.
EcoRI, EcoRV, PvuII and BamHI) showed them to be
almost completely unrelated (105–109). When crystal
structures appeared (110–114), commonalities began to
emerge. The motif PD-(D/E)XK was identiﬁed as a
common feature (115,116). This motif also appeared in
other nucleases, e.g. lambda exonuclease (117) and the
Tn7 transposase protein TnsA (118). This motif is the
catalytic core of a Mg2+-dependent nuclease.
REBASE, the Restriction Enzyme Database set up by
Rich Roberts to keep track of RM speciﬁcities and
indicate how to acquire the enzymes, made possible the
next phase of understanding. First on paper (119,120),
then via the nascent Internet by File Transfer Protocol
and ﬁnally on the World Wide Web (1,121) this resource
makes available a focused organized data set allowing
computational analysis of sequences and structures as
well as access to individual topics of interest [e.g.
(99,122–129)].
Recently, Sau3A (104) and several other REases proved
able to cut DNA/RNA hybrids (130). The rarity of this
property (6 of 223 surveyed) suggests that any biological
roles for this ability will be specialized, but the property
could be used to study the ubiquitous small RNA mol-
ecules that regulate expression in all domains of life (131).
FURTHER HIGHLIGHTS IN THE STUDY OF TYPE III
R-M SYSTEMS
Type III enzymes have properties that are intermediate
between Types I and II (Table 1 and Figure 1). In
general, Type III enzymes recognize asymmetric
sequences, cleave 25–27 nucleotides away from their rec-
ognition site and use ATP and SAM as cofactors,
although they do not have an absolute requirement for
the latter. Particularly interesting topics include control
of the phage-borne R.EcoP1I REase activity following in-
fection and how newly replicated DNA can be protected
when only one strand of the recognition sequence is pro-
tected by methylation (132–139).
An early result showed that two copies of the target site
were required for DNA cleavage but that these sites had to
be in a head-to-head orientation (135,140). A head-to-tail
orientation prevented cleavage. How this communication
between the two target sites was achieved when ATP hy-
drolysis was insufﬁcient for DNA translocation like the
Type I enzymes (59) has provoked much discussion
(141). It appears that DNA looping may have a role in
bringing the sites together (142,143), but recent single-
molecule analyses (144,145) show strong evidence for
enzyme diffusion along the DNA triggered by an ATP-
dependent conformational change as a novel mechanism
for bringing two copies of the enzyme together to give
cleavage, see also (83,146). The long-awaited atomic struc-
ture of a Type III R-M enzyme should resolve many of the
complexities of these enzymes [AK Aggarwal, personal
communication (147,148)].
FURTHER HIGHLIGHTS IN THE STUDY OF TYPE IV
RESTRICTION SYSTEMS
Modiﬁcation-dependent restriction was ﬁrst observed
with populations of phage T4 that contained
hydroxymethylcytosine (hm5C)-substituted DNA (13),
reviewed in (149,150). This original discovery relied on
the fortuitous use of Shigella dysenteria SH as permissive
host: it lacks both of the E. coliK-12 hm5C-targeted endo-
nucleases and also the donor for the protective modiﬁca-
tion, glucosylation. This allowed glucoseless phage to be
propagated in Shigella, while picking apart the E. coli
K-12 set of restricting and modifying genes.
Key advances in the early years lay in determining the
nature of the modiﬁcations in T-even phage DNA and the
genes that enable them. hm5C is incorporated into
the DNA during synthesis, and then glucose residues are
added in different conﬁgurations. The host provides the
glucosyl donor (151,152), while the phage provides the
glucosyltransferase enzymes (153–155). With these
genetic tools in hand, the host genes mediating the
phage restriction activity were identiﬁed (156). These
were named rglA and rglB (restricts glucoseless phage)
because they mediate restriction of hmC-containing
phage that lack the further glucose modiﬁcation.
In the 1980s, the focus switched to other modiﬁcations,
particularly m5C, with efforts to clone Type II MTases
and eukaryotic DNA into E. coli (157–159). The m5C-
speciﬁc functions mcrA and mcrB were mapped (160)
and were shown to be identical to the rglA and rglB
genes (161). A third modiﬁcation–dependent enzyme was
found to recognize m6A as well as m5C (162). Using the
genetic tools described above, glucose-speciﬁc activity was
identiﬁed (163,164). Most recently, a newly described
Type II restriction enzymes grouped by cleavage properties
Type IIP homodimer      Type IIS Type IIB
Type IIE Type IIF
Type II monomer (eg BcnI)
Cleave, detach, rotate
reattach
Figure 3. Type II restriction enzymes grouped by cleavage properties.
‘Orthodox’IIP enzymes (e.g. EcoRI, EcoRV) cut at the recognition site.
Type IIS cut away from the site (e.g. FokI, BﬁI). Type IIB require two
recognition sites and cut on the outside (e.g. BplI). Type IIE require
two recognition sites, and one of the two sites acts as allosteric effector
(e.g. EcoRII). Type IIF require two sites and cut at both sites as a
tetramer after bringing the two regions together by looping the DNA
(e.g. SﬁI). Enzymes such as BcnI act as a monomer, in contrast to most
Type II REases that act as dimers. See Table 2 and text for further
details.
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DNA modiﬁcation (165) has provided new targets (166)
for Type IV enzymes: phosphorothioate linkages in the
phosphodiester backbone.
The utility of all these discoveries was, at ﬁrst, the ability
to avoid them (167–169): these restriction systems were
found to underlie difﬁculties encountered in the introduc-
tion of foreign MTases into E. coli (157,158,170). On the
positive side, use of Type IV restriction in vivo also
allowed enrichment of clone libraries for active eukaryotic
genomic sequence, since much transcriptionally silenced
DNA is heavily methylated [e.g. (171)].
Type IV enzymes have aroused considerable interest in
recent years following the rediscovery of hm5C in the
DNA of higher eukaryotes (172–175). This ﬁnding could
portend the discovery of further, as yet unknown or neg-
lected, DNA modiﬁcations. The ability of Type IV
enzymes to distinguish between C, m5C, hm5C and
other molecular variations of cytosine implicates these
enzymes as useful tools for studies of epigenetic phenom-
ena; the commercially available enzyme McrBC has been
used for the study of such modiﬁcation patterns (176,177).
Much history may remain to be written. The accom-
panying review focuses on structural and enzymatic
properties of the systems that are known, and sketches
some of the evolutionary pressures faced by restriction
systems as they compete with each other and with
invading replicons.
CONTROL OF RESTRICTION
Double-stranded cleavage of cellular DNA is extremely
deleterious to the host cell, even when it can be repaired.
Early in the study of restriction systems, the ease of
moving systems among strains with differing systems by
conjugation or transduction was noted. This suggested
that regulation must be present to enable exchange of
activities. More recently, the sporadic distribution of
R-M systems in genomes of closely related strains
strongly suggests that acquisition of a new system is a
relatively frequent event in nature as well. Thus, coordin-
ation of expression or activity of the R-M activities is a
key research topic. Transcriptional or translational
control of Type I systems has not been documented,
despite efforts to ﬁnd it (8,178). However post-transla-
tional control is exerted at several levels and is described
in the accompanying review on Type I R-M systems. The
control of Type II R-M systems recapitulates the mechan-
isms for other regulatory systems and is described here.
Transcriptional control of Type II enzyme expression
In contrast to Type I enzymes, transcriptional control has
been found for Type II enzymes. Most of the Type II
systems that have been examined have the problem of
integrating control of the modiﬁcation and restriction
activities separately, since they are embodied in separate
proteins. Once again, the introduction of these genes into
a naı¨ve host is of special interest.
Control of restriction of Type II enzymes: the case
of EcoRI
Expression of the MTase gene and methylation of the host
DNA before synthesis of the REase is the obvious solution
and the so-called ‘Hungarian trick’ was the basis for the
cloning of many of the ﬁrst restriction enzymes (179). The
lab of Ichizo Kobayashi investigated the regulation of the
EcoRI gene, ecoRIR (180–182). This gene is upstream of
the modiﬁcation gene, ecoRIM. The M gene has its own
promoters embedded in ecoRIR and no transcription ter-
minator between the genes, so ecoRIM can be transcribed
with and without ecoRIR. Using primer extension to
locate the start sites and gene fusions to assess expression,
two adjacent promoters for ecoRIM as well as two reverse
promoters were found within ecoRIR. These convergent
promoters negatively affect each other [as in lambda
(183)]. Transcription from the reverse promoter is
terminated by the forward promoters and generates a
small antisense RNA. The presence of the antisense
RNA gene in trans reduced lethality mediated by
cleavage of under-methylated chromosomes after loss of
the EcoRI plasmid (post-segregational killing) (182,184).
Dual transcription control by C proteins
The Blumenthal laboratory provided the ﬁrst evidence for
temporal control in the plasmid-based PvuII system of
Proteus vulgaris (108,185). A similar open reading frame
with similar function was also found contemporaneously
in the BamHI system (186,187). In the PvuII system, the
MTase is expressed without delay from an independent
promoter and protects the host DNA. The REase gene
is in an operon with that for an autogenous activator/re-
pressor protein, C.PvuII. Low basal expression from the
pvuIIC promoter leads to accumulation of the activator,
thereby boosting transcription of the C and REase genes
(108,185) (Figure 4).
The C protein binds to palindromic DNA sequences
(C boxes) deﬁning two sites upstream of its gene: OL,
associated with activation, and OR, associated with repres-
sion. The C protein activates expression of its own gene as
well as that of the REase (188). The regulation is similar to
gene control in phage lambda: differential binding
afﬁnities for the promoters in turn depend on differential
DNA sequence and dual symmetry recognition. C
proteins belong to the helix-turn-helix family of transcrip-
tional regulators that include the cI and cro repressor
proteins of lambdoid phages.
In the wake of PvuII and BamHI, other R-M systems
were discovered that were controlled by C proteins,
including BglII (189), Eco72I (190), EcoRV (191),
Esp396I (192) and SmaI (193). Currently, Rebase lists 19
documented C proteins, as well as 432 putatives based on
sequence data (16 September 2013, http://rebase.neb.
com). The organization of the genes in the system and
regulatory details differ from system to system
(108,185,194). There is no published evidence addressing
the question of whether R-M systems as a whole evolve in
concert with the C proteins. An interesting system would
be one homologous to a C-regulated system but without
the C gene.
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Structure of C proteins
The ﬁrst structures of C-proteins appeared in 2005:
C.AhdI from Geoff Kneale’s laboratory (195), and
C.BclI from a consortium of workers (196). The structures
were solved without bound DNA, and while they con-
ﬁrmed the close relationship between C-proteins and
helix-turn-helix DNA-binding proteins in general, they
did not reveal details of the interactions between
C-proteins and their C-box binding sites in DNA
(195,197–204). That came 4 years later with the crystal
structure of C.Esp1396I bound to DNA (205). This struc-
ture, coupled with experimental investigations, revealed
the mechanics of the genetic switch and the nature of
the sequence-speciﬁc and non-speciﬁc interactions with
the promoters controlling the C/R and M genes (205–
208). C.Esp1396I bound as a tetramer, with two dimers
bound adjacently on the 35-bp operator sequence OL+OR
(206). This cooperative binding of dimers to the DNA
operator controls the switch from activation to repression
of the C and R genes.
Biological consequences of transcriptional regulation
The existence of C proteins explains why it was difﬁcult to
introduce some R-M genes in E. coli. For instance, the
BamHI system of Bacillus amyloliquefaciens could only
be maintained in E. coli when the REase and MTase
were present on one plasmid with an additional copy of
the MTase on a second plasmid (209). Further analysis
suggested that in Bacillus subtilis, a host more closely
related to the original expression of R-M was even more
stringently regulated (109). C.BamHI enhanced activity of
the REase 100-fold in E. coli, but at least 1000-fold in
B. subtilis. In E. coli, the C protein repressed expression
of the MTase 15-fold. The B. subtilis vegetative RNA
polymerase is known be more stringent in its promoter
sequence requirements than that of E. coli (210),
possibly accounting for the difference in behaviour in
the two species.
Crosstalk among the C genes of similar speciﬁcity can
allow exclusion with R-M systems of different sequence
speciﬁcities because of the premature activation of the R
gene. The pvuIIC and bamHIC genes deﬁne one incom-
patibility group of exclusion, whereas ecoRVC deﬁnes
another (211). Entry of a second R-M system thus
becomes lethal, a phenomenon called ‘apoptotic mutual
exclusion’ (211).
THE IMPACT OF RESTRICTION ENZYMES
The technical ingenuity applied to the use of restriction
enzymes warrants a separate detailed Survey and
Summary or indeed an entire book. For instance, their
use led to the production of insulin from recombinant
bacteria and yeast by Genentech, thus greatly increasing
the supply for diabetics and the production of a recom-
binant vaccine for Hepatitis B by Biogen to treat the
hundreds of millions of people at risk of infection by
this virus. More recently they have been redesigned to
create artiﬁcal nucleases, the Zinc-ﬁnger nucleases and
the TAL-effector nucleases, which have potential for
gene targeting and gene therapy (212). Here, we limit our-
selves to a few other examples with signiﬁcant scientiﬁc or
public impact.
Genetic engineering
Type II enzymes yielded many practical beneﬁts, as E. coli
K12, its genes and its vectors became the workhorses of
molecular biology in the 1970s for cloning, generation of
libraries, DNA sequencing, detection and overproduction
of enzymes, hormones, etc [e.g. (45,213–224)]. The appli-
cations of Type II enzymes continued to expand, espe-
cially after the arrival of synthetic DNA, in vitro
packaging of DNA in phage particles and improved bac-
terial hosts and vectors for overexpression and stabiliza-
tion of proteins [see e.g. (225–232)].
A historical perspective on the above topics is beyond
the scope of this review. However, a couple of vignettes
illustrate how use of REases enabled the research commu-
nity to leverage a store of understanding to create tools for
new advances.
The lacZ gene, which had EcoRI sites suitable for early
vectors, and its encoded enzyme, beta-galactosidase, had a
long history of investigation. Its utility in the creation of
cloning vectors relied on identiﬁcation of domains within
the encoded protein, namely a large catalytic domain and
The PvuII and Esp1396I operons
M RC
pmod 1, 2
pres
pres 1
MRC
pres
pres 1
OmOROL
pmod
OROL PvuII
Esp1396I
Figure 4. Intricate control of restriction in the operons of the Type II
R-M systems of PvuII and Esp1396I by controlling C proteins. A small
C gene upstream of, and partially overlapping with, R is coexpressed
from pres1, located within the M gene, at low level with R after entry of
the self-transmissible PvuII plasmid into a new host, while M is ex-
pressed at normal levels from its own two promoters pmod1 and pmod2
located within the C gene. A similar C protein operates in Esp1396I,
but in this case the genes are convergently transcribed with transcrip-
tion terminator structures in between, and M is expressed from a
promoter under negative control of operator OR, when engaged by C
protein in a manner similar to that of the PvuII system. Brieﬂy, the C
protein binds to two palindromic sequences (C boxes) deﬁning operator
sites OR and OL upstream of the C and R genes. After initial low-level
expression of C.PvuII protein from the weak promoter pres1, positive
feedback by high-afﬁnity binding of a C protein dimer to the distal OL
site later stimulates expression from the second promoter pres, resulting
in a leaderless transcript and more C and R protein. The proximal site
OR is a much weaker binding site, but C protein bound at OL enhances
the afﬁnity of OR for C protein, and at high levels of C protein, the
protein-OR complex downregulates expression of C and R. In this way,
C protein is both an activator and negative regulator of its own tran-
scription. In addition, it is a negative regulator of M, which makes
sense as overmethylation of DNA may also be harmful to the cell
(see text for further details). C.Esp1396I controls OR, OL and OM in
a similar manner as described above. In this way, C proteins keep both
R-M under control, and have been tentatively identiﬁed in >300 R-M
systems (Table 2).
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a small multimerization domain. This was discovered by
the Muller-Hill group in 1974 (233,234). The 25
N-terminal residues of the small domain can be replaced
by peptides of any size and origin without destroying the
ability of the multimerization domain to interact with the
catalytic domain (233,234). As a result, vectors with short
stretches of DNA carrying multiple restriction sites could
be created (235–237). Cloning into these sites interrupted
the translation of the small domain, destroying its ability
to interact with the separately expressed large one. This
made possible rapid screening of bacterial colonies on an
agar plate for those lacking the activity of LacZ using a
colour assay.
In addition, vectors carrying the intact gene but with
multiple cloning sites allowed EcoRI-based DNA con-
structs for transcriptional and translational fusions to
the lacZ gene (238–250). The majority (90%) of such
LacZ-fusion proteins are stable, allowing puriﬁcation of
chimeric antigens, as well as detection of positive clones
with colour assays (238,251). Mutagenesis studies in the
laboratory of Jeffrey Miller used the lacZ gene in phage
f1, allowing the rapid detection of spontaneous or induced
base substitutions and frameshifts (252–254). This resulted
in e.g. LacZ-transgenic mice for studies on DNA damage
in different organs and tissues in mammalian cells
(255,256).
DNA ﬁngerprinting
Restriction enzymes are tools for monitoring Restriction
Fragment Length Polymorphisms, allowing the location
of mutations, generation of human linkage maps, identi-
ﬁcation of disease genes (such as sickle cell trait or
Huntington disease), and last, but not least, the DNA
ﬁngerprinting technique developed by Alec Jeffreys
(257–267). DNA ﬁngerprinting (268) allows the solution
of paternity cases, the identiﬁcation of criminals and their
victims and the exoneration of the falsely accused. The use
of REases in this system enabled the creation of suitable
procedures for such identiﬁcation, although PCR has
largely displaced REases in this application.
REases have also proven useful for identifying patho-
genic bacterial strains, most recently of S. aureus sp with
antibiotic-resistance and virulence factors mediated by
mobile genetic elements, e.g. the methicillin-resistant
S. aureus (MRSA) bacteria (269). Such strains pose a
great threat to humans and animals (270).
FINAL THOUGHTS
In 1977, Werner Arber proposed that REases might have
additional functions in the cell (271), and this is an idea to
keep in mind given that much of the study of restriction
enzymes has been aimed at creating tools rather than a
basic study of their behaviour in their natural hosts.
For example, the actions of translocating enzymes such
as the Type I and IV enzymes at a replication fork or other
variant structure are one such possibility (272,273). This
activity may seem of arcane interest, but a broader under-
standing especially of the translocating enzymes could
further understanding of genome stabilization activities
in all domains of life. Applications to genome manipula-
tion or medicine could emerge. Action at aberrant struc-
tures is a major topic of interest in medicine (274).
Lastly, it is interesting to speculate on the condition of
molecular biology and all of its associated sciences at the
present day if the simple experiment of spreading bacteria
and phage on agar plates to follow the restriction-modiﬁ-
cation phenomenon (13–15) had not been pursued. It is
clear that a multi-billion dollar biotechnology industry
would not have been spawned, medical diagnostics and
the treatment of many diseases would have been severely
retarded, genomics and genome sequencing projects would
have been difﬁcult if not impossible and their support of
bioinformatics and evolutionary studies would also not
have been possible, thus greatly diminishing our current
appreciation of the spectacular diversity of life on earth.
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